share_log

Veru Shares Are Trading Higher Following Publication of Briefing Documents Ahead of the Nov. 9 FDA Adcom Meeting for Its COVID-19 Treatment Candidate.

Veru Shares Are Trading Higher Following Publication of Briefing Documents Ahead of the Nov. 9 FDA Adcom Meeting for Its COVID-19 Treatment Candidate.

在11月9日FDA Adcom会议之前发布简报文件后,Veru的股价上涨,VERU的候选新冠肺炎治疗方案。
Benzinga ·  2022/11/07 10:31

Veru shares are trading higher following publication of briefing documents ahead of the Nov. 9 FDA Adcom meeting for its COVID-19 treatment candidate.

在11月9日FDA为其新冠肺炎候选药物举行的Adcom会议之前,Veru的股价在简报文件公布后走高。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发